• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Big data shaping clinical trial landscape-Greater role for pharmacoeconomics in Asia.

作者信息

Jakovljevic Mihajlo, Lu Kevin

机构信息

Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.

Institute of Comparative Economic Studies, Hosei University, Tokyo, Japan.

出版信息

Front Public Health. 2022 Oct 26;10:1037082. doi: 10.3389/fpubh.2022.1037082. eCollection 2022.

DOI:10.3389/fpubh.2022.1037082
PMID:36388382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9644335/
Abstract
摘要

相似文献

1
Editorial: Big data shaping clinical trial landscape-Greater role for pharmacoeconomics in Asia.社论：大数据塑造临床试验格局——药物经济学在亚洲发挥更大作用
Front Public Health. 2022 Oct 26;10:1037082. doi: 10.3389/fpubh.2022.1037082. eCollection 2022.
2
Growing application of pharmacoeconomics and outcomes research in health-care decision-making in the Asia-Pacific region.药物经济学与结果研究在亚太地区医疗保健决策中的应用日益广泛。
Value Health. 2009 Nov-Dec;12 Suppl 3:S1-2. doi: 10.1111/j.1524-4733.2009.00618.x.
3
Bridging the gap in pharmacoeconomics and outcomes research between researchers, policymakers, and practitioners in the Asia-Pacific region.弥合亚太地区研究人员、政策制定者和从业者在药物经济学与结果研究方面的差距。
Value Health. 2012 Jan-Feb;15(1 Suppl):S1-2. doi: 10.1016/j.jval.2011.11.021.
4
What is next for pharmacoeconomics and outcomes research in Asia?亚洲药物经济学与结果研究的未来走向如何？
Value Health. 2004 Mar-Apr;7(2):118-32. doi: 10.1111/j.1524-4733.2004.72330.x.
5
Evaluation of Quality of Pharmacoeconomic Studies in Asia-Pacific Region and Identification of Influencing Variables.亚太地区药物经济学研究质量评估及影响因素识别
Value Health Reg Issues. 2018 May;15:70-75. doi: 10.1016/j.vhri.2017.07.007. Epub 2017 Sep 9.
6
Editorial: Challenges of pharmacoeconomics in global health arena-Contemporary momentum in the early 2020s.社论：全球卫生领域中药效经济学的挑战——21世纪20年代初的当代发展态势
Front Public Health. 2023 Apr 13;11:1189671. doi: 10.3389/fpubh.2023.1189671. eCollection 2023.
7
Gap analysis in manufacturing, innovation and marketing of medical devices in the Asia-Pacific region.亚太地区医疗器械制造、创新和营销的差距分析。
Expert Rev Pharmacoecon Outcomes Res. 2022 Oct;22(7):1043-1050. doi: 10.1080/14737167.2022.2086122. Epub 2022 Jun 8.
8
Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.新千年的药物经济学。制药行业视角。
Pharmacoeconomics. 1998 Feb;13(2):175-80. doi: 10.2165/00019053-199813020-00002.
9
Emerging role of pharmacoeconomics in the research and development decision-making process.药物经济学在研发决策过程中的新作用。
Pharmacoeconomics. 2001;19(7):753-66. doi: 10.2165/00019053-200119070-00004.
10
Expert review of pharmacoeconomics and outcomes research: high impact articles from 2023.
Expert Rev Pharmacoecon Outcomes Res. 2024 Jun;24(5):577-579. doi: 10.1080/14737167.2024.2339945. Epub 2024 Apr 9.

引用本文的文献

1
Variability in research culture across busy catheterisation labs in the Asia-Pacific region.亚太地区繁忙的导管插入实验室之间研究文化的差异。
AsiaIntervention. 2024 Feb 29;10(1):26-33. doi: 10.4244/AIJ-D-23-00005. eCollection 2024 Feb.

本文引用的文献

1
Gap analysis in manufacturing, innovation and marketing of medical devices in the Asia-Pacific region.亚太地区医疗器械制造、创新和营销的差距分析。
Expert Rev Pharmacoecon Outcomes Res. 2022 Oct;22(7):1043-1050. doi: 10.1080/14737167.2022.2086122. Epub 2022 Jun 8.
2
Therapeutic innovations: the future of health economics and outcomes research - increasing role of the Asia-Pacific.治疗创新：卫生经济学与结果研究的未来——亚太地区作用的增强
J Med Econ. 2021 Nov;24(sup1):i-iii. doi: 10.1080/13696998.2021.2014164.
3
Predictors of (in)efficiencies of Healthcare Expenditure Among the Leading Asian Economies - Comparison of OECD and Non-OECD Nations.亚洲主要经济体医疗保健支出（无）效率的预测因素——经合组织国家与非经合组织国家的比较
Risk Manag Healthc Policy. 2020 Oct 21;13:2261-2280. doi: 10.2147/RMHP.S266386. eCollection 2020.
4
Real GDP growth rates and healthcare spending - comparison between the G7 and the EM7 countries.实际 GDP 增长率与医疗保健支出——G7 国家和 EM7 国家的比较。
Global Health. 2020 Jul 16;16(1):64. doi: 10.1186/s12992-020-00590-3.